Finals26 Apr 2023 09:00
Audited results out going concern box ticked. Well the accounts look pretty much the same as last year. We loose money but survive on 500k of revenues existing cash contingencies and CLN’s if needed. So anyone invested here or intending to invest should be well aware that this is a very high risk stock.
But the science is absolutely unbelievable! The progress that this team has made in medical imaging and phase 1 treatments is nowhere near reflective in the SP. That has been recognised by the company.
“….. we remain firmly focused on the medium-term commercial prospects for our unique products and are confident that shareholder patience will be eventually rewarded..”
“.. It is five years since IQ-AI acquired Imaging Biometrics. Throughout that time the IB team have worked continuously and intensively to innovate and develop what has now become a valuable portfolio of medical IP. We believe that the cumulative accretion of value during this time is not adequately reflected in the current market valuation of the Company, and we are now considering how best to address this anomaly …..”
So it’s no need to deramp the finances. We know. We are also aware of the significant skin our CEO has in this and the director options. The mcap is only 5m!
Likewise the science is still future looking, it takes time to develop this tech and meet regulatory compliance.
However, a point will come when value will out. I hope given Mike’s email and now that we are out of the close period together with the comments in the finals that point is soon but again no guarantees as to when.
So really nothing here has changed.
I have a balanced position and am waiting for 50p minimum and expect anything between 1p and 20p until it arrives. Hence have a few, enough to make a difference but not too many incase it doesn’t work out.
Usual caveats
Trek
Sign In
Follow the stocks
